Copy Link Print Information

I-TAC/CXCL11 Protein, Human

1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

CXCL11, also known as IFN-inducible T-cell α-chemoattractant (I-TAC), belongs to the ELR-negative CXC chemokine family. CXCL11 is produced by a variety of cells including leukocytes, fibroblasts, and endothelial cells upon stimulation with interferons (IFNs). CXCL11 signals through CXCR3. CXCL11 is associated with pleiotropic functions including chemotactic migration, regulation of cell proliferation and self-renewal, increasing cell adhesion, and modulation of angiostatic effects. I-TAC/CXCL11 Protein, Human consists of 73 amino acids (F22-F94) and is expressed in E. coli.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: E. coli
  • Storage:
    Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
  • Experimental Validation Results for I-TAC/CXCL11 Protein, Human
  • Experimental Validation Results for I-TAC/CXCL11 Protein, Human
  • I-TAC/CXCL11 Protein, Human Product Image
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Service
Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Biological Activity

Description

CXCL11, also known as IFN-inducible T-cell α-chemoattractant (I-TAC), belongs to the ELR-negative CXC chemokine family. CXCL11 is produced by a variety of cells including leukocytes, fibroblasts, and endothelial cells upon stimulation with interferons (IFNs). CXCL11 signals through CXCR3. CXCL11 is associated with pleiotropic functions including chemotactic migration, regulation of cell proliferation and self-renewal, increasing cell adhesion, and modulation of angiostatic effects[1][2]. I-TAC/CXCL11 Protein, Human consists of 73 amino acids (F22-F94) and is expressed in E. coli.

Background

CXCL11 is mainly expressed in the lung, pancreas, thymus, peripheral blood leukocytes, spleen, and liver and is expressed at lesser levels in the intestine, placenta, and prostate. CXCL11 is located on human chromosome 4 and is mainly secreted by cancer cells, leukocytes, monocytes, dendritic cells, endothelial cells, and fibroblasts. CXCL11 attracts activated lymphocytes and NK cells to inflamed tissue and to tumors and inhibits the generation of novel blood vessels essential for tumor growth and tissue repair[1][2].
CXCL11 which can bind to two different chemokine receptors, CXCR3 and CXCR7. CXCL11 is characterized by the presence of 1 amino acid in between the 2 NH2-terminal cysteines. CXCL11 is usually expressed at low levels in homeostatic conditions, but is upregulated during cancer or infectious disease processes. CXCL11 is mainly induced by IFN-γ and IFN-β and is weakly induced by IFN-α. CXCL11 has potent chemoattractant activity for IL-2 activated T cells and transfected cell lines expressing CXCR3, but not freshly isolated T cells, neutrophils or monocytes. Simultaneous stimulation of fibroblasts or endothelial cells with IFN-γ and interleukin-1β or the TLR3 ligand double-stranded RNA resulted in a synergistic increase of CXCL11 production. In leukocytes, bacterial LPS and PGN even inhibited interferon-induced CXCL11 production. CXCL11 attracts activated T-helper 1 (Th1) lymphocytes and natural killer (NK) cells. Furthermore, CXCL11 can bind to CXCR7, which is associated with invasiveness and reduces apoptosis of tumor cells[1][2].
The diverse functions of CXCL11 include inhibiting angiogenesis, affecting the proliferation of different cell types, playing a role in fibroblast directed carcinoma invasion, increasing adhesion properties, suppressing M2 macrophage polarization, and facilitating the migration of certain immune cells[1][2].

In Vitro

Recombinant human CXCL11 (100 ng/mL) promotes proliferation and migration of IGROV-1 cells via CXCR3. Recombinant human CXCL11 (100 ng/mL; 5-60 min) increases the phosphorylated p44/42 and phosphorylated Akt in ovarian cancer cells[3].

Verified Bioactivity

1. The ED50 is <2.5 μg/mL as measured by the FLIPR assay using CHO cells transfected with Human CXCR3, the receptor of human CXCL11, corresponding to a specific activity of >400 units/mg.
2. The biological activity determined by a chemotaxis bioassay using activated human T-lymphocytes. The ED50 for this effect is 1.98 ng/mL in the presence of 1 ng/mL human IL-2, corresponding to a specific activity is 5.05×105 U/mg.
3. Measured by its ability to chemoattract BaF3 mouse pro-B cells transfected with human CXCR3. The ED50 for this effect is 1-5 ng/mL, corresponding to a specific activity is 2×105-1×106 U/mg.

MCE Validation Data

  • Purity - SDS-PAGE

    Purity - SDS-PAGE

    ≥ 95%, as determined by reducing SDS-PAGE.

  • Bioactivity - Cell-Based Assay

    Bioactivity - Cell-Based Assay

    The biological activity determined by a chemotaxis bioassay using activated human T-lymphocytes. The ED50 for this effect is 1.98 ng/mL in the presence of 1 ng/mL human IL-2, corresponding to a specific activity is 5.05×105 U/mg.

Technical Parameters

  • Species Human
  • Source E. coli
  • Tag Tag Free
  • Accession

    O14625 (F22-F94)

  • Gene ID
    6373  [NCBI]
  • Molecular Construction
    • N-term
    • CXCL11 (F22-F94)
      Accession # O14625
    • C-term
  • Protein Length

    Full Length of Mature Protein

  • Synonyms

    CXCL11; Interferon Gamma-Inducible Protein 9; Prev. SCYB11; C-X-C Motif Chemokine 11; Prev. SCYB9B; Beta-R1; I-TAC; Small Inducible Cytokine Subfamily B (Cys-X-Cys), Member 9B; H174; Small Inducible Cytokine B11; IP-9; Small-Inducible Cytokine B11; B-R1;

  • AA Sequence

    FPMFKRGRCLCIGPGVKAVKVADIEKASIMYPSNNCDKIEVIITLKENKGQRCLNPKSKQARLIIKKVERKNF

  • Predicted Molecular Mass

    8.3 kDa

  • Molecular Weight

    Approximately 10 kDa, based on SDS-PAGE under reducing conditions.

  • Purity

    ≥ 95%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Lyophilized powder

Formulation

1.Lyophilized from a 0.22 μm filtered solution of PBS.
2.Lyophilized from a 0.22 μm filtered solution of 20 mM PB, 150 mM NaCl, pH 7.4.
3.Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.
4.Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4, 0.2% SKL.
Please refer to the lot-specific COA for specific buffer information.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Storage & Stability

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Shipping

Room temperature in continental US; may vary elsewhere.

References

[1]. Proost P, et al. Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood. 2007 Jul 1;110(1):37-44. [Content Brief]

[2]. Proost P, et al. Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood. 2007 Jul 1;110(1):37-44. [Content Brief]

[3]. Qun Gao, et al. CXCL11 Signaling in the Tumor Microenvironment. Adv Exp Med Biol. 2021;1302:41-50. [Content Brief]

[4]. Tat-San Lau, et al. Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts. J Pathol. 2014 Jan;232(1):43-56. [Content Brief]

View More

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00

Measured by its ability to inhibit anti-CD3-induced proliferation of stimulated CTLL-2 mouse cytotoxic T cells. The ED50 this effect is 0.8023 μg/ml, corresponding to a specific activity is 1246.42 units/mg.

Assay Types
  • 1/16

    MedChemExpress Validation
     ≥ 95%, as determined by reducing SDS-PAGE.

  • 1/16

    MedChemExpress Validation
     The biological activity determined by a chemotaxis bioassay using activated human T-lymphocytes. The ED50 for this effect is 1.98 ng/mL in the presence of 1 ng/mL human IL-2, corresponding to a specific activity is 5.05×105 U/mg.

  • I-TAC/CXCL11 Protein, Human Product Image
    1/16
  • Experimental Validation Results for I-TAC/CXCL11 Protein, Human
  • Experimental Validation Results for I-TAC/CXCL11 Protein, Human
  • I-TAC/CXCL11 Protein, Human Product Image